Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024)
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2022-07-01
|
| Series: | Chinese Medical Journal |
| Online Access: | http://journals.lww.com/10.1097/CM9.0000000000002309 |
| _version_ | 1811204240664690688 |
|---|---|
| author | Fengjiang Qu Di Wu Yunjiang Liu Wei Gao Shu Wang Siyuan Wang Feng Jin Bo Chen Jian Huang Shanshan Sun Zhimin Fan Chinese Society of Breast Surgery Yanjie Yin Xiuyuan Hao |
| author_facet | Fengjiang Qu Di Wu Yunjiang Liu Wei Gao Shu Wang Siyuan Wang Feng Jin Bo Chen Jian Huang Shanshan Sun Zhimin Fan Chinese Society of Breast Surgery Yanjie Yin Xiuyuan Hao |
| author_sort | Fengjiang Qu |
| collection | DOAJ |
| first_indexed | 2024-04-12T03:09:18Z |
| format | Article |
| id | doaj.art-34b94858162c44d096fb2782dcb00b38 |
| institution | Directory Open Access Journal |
| issn | 0366-6999 2542-5641 |
| language | English |
| last_indexed | 2024-04-12T03:09:18Z |
| publishDate | 2022-07-01 |
| publisher | Wolters Kluwer |
| record_format | Article |
| series | Chinese Medical Journal |
| spelling | doaj.art-34b94858162c44d096fb2782dcb00b382022-12-22T03:50:25ZengWolters KluwerChinese Medical Journal0366-69992542-56412022-07-01135141753175510.1097/CM9.0000000000002309202207200-00016Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024)Fengjiang QuDi WuYunjiang LiuWei GaoShu WangSiyuan WangFeng JinBo ChenJian HuangShanshan SunZhimin FanChinese Society of Breast SurgeryYanjie YinXiuyuan Haohttp://journals.lww.com/10.1097/CM9.0000000000002309 |
| spellingShingle | Fengjiang Qu Di Wu Yunjiang Liu Wei Gao Shu Wang Siyuan Wang Feng Jin Bo Chen Jian Huang Shanshan Sun Zhimin Fan Chinese Society of Breast Surgery Yanjie Yin Xiuyuan Hao Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) Chinese Medical Journal |
| title | Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) |
| title_full | Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) |
| title_fullStr | Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) |
| title_full_unstemmed | Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) |
| title_short | Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024) |
| title_sort | clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in china a multicenter single arm open validation trial csbrs 024 |
| url | http://journals.lww.com/10.1097/CM9.0000000000002309 |
| work_keys_str_mv | AT fengjiangqu clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT diwu clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT yunjiangliu clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT weigao clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT shuwang clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT siyuanwang clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT fengjin clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT bochen clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT jianhuang clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT shanshansun clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT zhiminfan clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT chinesesocietyofbreastsurgery clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT yanjieyin clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 AT xiuyuanhao clinicalevaluationofthefirstdomesticallyproducedgenericisosulfanblueinjectioninsentinellymphnodebiopsyforearlybreastcancerinchinaamulticentersinglearmopenvalidationtrialcsbrs024 |